Medical holographic company RealView Imaging obtains $10m

23 July 2020 (Last Updated July 23rd, 2020 14:50)

Israel-based medical holography company RealView Imaging has closed a $10m Series C financing round.

Medical holographic company RealView Imaging obtains $10m
The HOLOSCOPE-i system is expected to help physicians to view and directly interact with hyper-realistic 3D holograms of the patient’s actual anatomy. Credit: RealView Imaging Ltd.

Israel-based medical holography company RealView Imaging has closed a $10m Series C financing round.

The round was joined by new investors OurCrowd and Judith and Kobi Richter, along with the company’s existing shareholders, including Dr Shimon Eckhouse, Zohar Gilon and Uzia Galil and other technology and medical Israeli entrepreneurs.

Medinol founder and chairman Dr Kobi Richter and Cardiology Institute at Sheba Medical Center former director Prof Michael Eldar secured seats on the company’s board, following the closing of Series C round.

RealView is currently developing holographic augmented reality (AR) medical system called HOLOSCOPE-x to facilitate precise minimally invasive interventional procedures. The system is designed to project 3D holographic images inside the patient’s body by creating 3D volumetric holograms from medical imaging data.

Dr Shimon Eckhouse said: “We are now focused on the commercialisation of the HOLOSCOPE-i system, initially in North America and in Europe.

“By incorporating medical holography into routine clinical workflow, we expect to revolutionise the way clinicians engage with 3D medical imaging.”

The HOLOSCOPE-i system is expected to help physicians view and directly interact with hyper-realistic 3D holograms that float in free space at hands reach during interventional procedures. Its advanced 3D interactive visualisation tools empower imaging-based minimally invasive medical interventions.

Dr Kobi Richter said: “RealView has created a unique solution that will address fundamental usability requirements and a wide range of clinical needs for advanced imaging.

“Given the company’s broad IP portfolio and technology maturity, I believe RealView can significantly impact the growing field of structural heart interventions, as well as additional future clinical fields such as electrophysiology and interventional oncology procedures.”

In 2017, RealView integrated the Intel RealSense SR300-Series camera into the HOLOSCOPE-i system.